Host gene-encoded severe lung TB: From genes to the potential pathways

Genes and Immunity

Volumn 13, Issue 8, 2012, Pages 605-620

  Ganachari, M ^a,b   Guio, H ^c,d   Zhao, N ^a,b   Flores Villanueva, P O ^a,b,e  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c NGO ALBIOTEC   (Peru)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

disease severity; genetics; MCP 1; MMP 1; tuberculosis

Indexed keywords

1 AMINO 3 CYCLOPROPYLAMINO 7 (4 ISOPROPYLBENZYL) 7H PYRROLO[3,2 F]QUINAZOLINE; GELATINASE B; INTERSTITIAL COLLAGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEINASE ACTIVATED RECEPTOR 1;

ARTICLE; BACTERIAL TRANSMISSION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; GENE LOCUS; GENETIC CODE; GENOTYPE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LUNG TUBERCULOSIS; MICROARRAY ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE;

ADULT; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; CELL LINE; CHEMOKINE CCL2; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENE EXPRESSION REGULATION; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTOR, PAR-1; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84870902456     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2012.39     Document Type: Article

References (49)

1. Flores-Villanueva PO, Ruiz-Morales JA, Song CH-H, Flores LM, Jo E-K, Montaño M et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 2005; 12: 1649-1658.
2. Ganachari MM, Ruiz-Morales JA, Gomez de la Torre Pretell JC, Dinh J, Granados J, Flores-Villanueva PO. Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCGvaccinated individuals. PLoS ONE 2010; 5: e8881.
3. Tobin DM, Roca FJ, Sungwhan FO, McFarland R, Vickery TV, Ray JP et al. Host genotype-specific therapies can optimize the inflammatory response to Mycobacterial infections. Cell 2012; 148: 434-446.
4. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R et al. A mutation in the interferon-g-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335: 1941-1949.
5. Ottenhoff TH, Kumararatne D, Casanova JL. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today 1998; 19: 491-494.
6. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000; 11: 321-333.
7. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20: 581-620.
8. Braun MC, Lahey E, Kelsall BL. Selective suppression of IL-12 production by chemoattractants. J Immunol 2000; 164: 3009-3017.
9. Omata N, Yasutomi M, Yamada A, Iwasaki H, Mayumi M, Ohshima Y. Monocyte chemoattractant protein-1 selectively inhibits acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 immune response. J Immunol 2002; 169: 4861-4866.
10. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Glaude RP, Corless CL et al. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 1995; 155: 4838-4843.
11. Bradley K, McConnell-Breui S, Crystal RG. Collagen in the human lung-quantitation of rates of synthesis and partial characterization. J Clin Invest 1975; 55: 543-550.
12. Chang JC, Wysocki A, Tchou-Wong KM, Moskowitz N, Zhang Y, Rom WN. Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax 1996; 51: 306-311.
13. Friedland JS, Shaw TC, Price NM, Dayer JM. Differential regulation of MMP-1/9 and TMP-1 secretion in human monocytes cells in response to Mycobacterium tuberculosis. Matrix Biol 2002; 21: 103-110.
14. Hoheisel GU, Sack U, Hui DS, Lai F, Chan KS, Choi CH et al. Immunochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculosis pleuritis. Pneumologie 2004; 58: 305-308.
15. Hoheisel GU, Sack U, Hui DS, Huse K, Chan KS, Chan KK et al. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculosis pleuritis. Tuberculosis 2001; 81: 203-209.
16. Iglesias D, Alegre J, Aleman C, Ruiz E, Soriano T, Armadans LI et al. Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions. Eur Respir J 2005; 25: 104-109.
17. Elkington P, Shiomi T, Breen R, Nuttall RK, Ugarte-Gil CA, Walker NF et al. MMP-1 drives immunopathology in human and transgenic mice. J Clin Invest 2011; 121: 1827-1833.
18. Wright EK, Page SH, Barber SA, Clements JE. Prep1/Pbx2 complexes regulate CCL2 expression through the-2578 guanine polymorphism. Genes Immun 2008; 9: 419-430.
19. Page SH, Wright EK, Gama L, Clements JE. Regulation of CCL2 expression by upstream TALE homeodomain protein-binding site that synergizes with the site created by the A-2578G SNP. Plos One 2011; 6: e22052.
20. Rovin BH, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259: 344-348.
21. Wyatt CA, Coon CI, Gibson JJ, Brinckerhoff CE. Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. Cancer Res 2002; 62: 7200-7202.
22. Reutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ et al. A single nucleotide polymorphism in the matrix metalloproteinase promoter creates an Ets binding site and augments transcription. Cancer Res 1998; 58: 5321-5325.
23. Wejse C, Gustafson P, Nielsen J, Gomes VF, Aaby P, Andersen PL et al. Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course. Scand J Infect Dis 2008; 40: 111-120.
24. Raaby L, Bendix-Struve M, Nielsen J, Wejse C. Inter-observer variation of the Bandim TB-score. Scand J Infect Dis 2009; 41: 220-223.
25. Harrison AC. Clinical investigation and assessment of tuberculosis. Guidelines for tuberculosis control in New Zealand. New Zealand Ministry of Health: Wellington, New Zealand, 2003.
26. Gie R. Diagnostic atlas of intrathoracic tuberculosis in children-a guide for low income countries. International Union Against Tuberculosis and Lung Disease: New York, NY, USA, 2003.
27. Davis JM, Ramakrishnan L. The role of the granuloma in expansion and dissemination of early tuberculosis infection. Cell 2009; 136: 37-49.
28. Scott HM, Flynn JL. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect Immun 2002; 70: 5946-5954.
29. Peters W, Cyster JG, Mack M, Schlondorff D, Wolf AJ, Ernst AJ et al. CCR2-dependent trafficking of F4/80dim macrophages and CD11cdim/intermediate dendritic cells is crucial for T cell recruitment to lungs infected with Mycobacterium tuberculosis. J Immunol 2004; 172: 7647-7653.
30. Schmitt E, Meuret G, Stix L. Monocyte recruitment in tuberculosis and sarcoidosis. Br J Haematol 1977; 35: 11-17.
31. Basaraba RJ. Cell-mediated immune responses in tuberculosis. Ann Rev Immunol 2008; 27: 393-422.
32. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, Coughlin SR. Molecular and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl Acad USA 1994; 91: 2752-2756.
33. Boire S, Covic L, Agarvai A, Jacques S, Sherifi S, Kuliopulos A. PAR1 is a matrix metalloproteinase-1 receptor that promotes invasion and tumorogenesis of breast cancer cells. Cell 2005; 120: 303-313.
34. Pforte A, Schiessler A, Gais P, Beer B, Ehlers M, Schutt C et al. Expression of CD14 correlates with lung function impairment in pulmonary sarcoidosis. Chest 1994; 105: 349-354.
35. Umino T, Skols CM, Pirruccello SJ, Spurzem JR, Rennard SI. Two-colour flowcytometric analysis of pulmonary alveolar macrophages from smokers. Eur Respir J 1999; 13: 894-899.
36. Saito N, Pulford KA, Breton-Gorious J, Masse JM, Mason DY, Cramer EM. Ultraestructural localization of the CD68 macrophage-associated antigen in human neutrophils and monocytes. Am J Pathol 1991; 139: 1053-1059.
37. Flynn JL, Goldsten MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2: 561-572.
38. Skold M, Behar SM. Tuberculosis triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J Immunol 2008; 181: 6349-6360.
39. Lavebratt C, Apt AS, Nokonenko BV, Schalling M, Shurr E. Severity of tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9. J Infect Dis 1999; 180: 150-155.
40. Kim M-J, Wainwright HC, Locketz M, Bekker L-G, Walther GB, Dittrich C et al. Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMB0 Mol Med 2010; 2: 258-274.
41. Elkington PT, Ugarte-Gil CA, Friendland JS. Matrix metalloproteinases in tuberculosis. Eur Respir J 2011; 38: 456-464.
42. 2\+. Biochem J 2003; 374: 281-296.
43. Feng WX, Mokrousov I, Wang BB, Nelson N, Jiao WW, Wang J et al. Tag SNP polymorphism of CCL2 and its role in clinical tuberculosis in Han Chinese pediatric population. PLoS One 2011; 6: e14652.
44. WHO. Working Group. Use and interpretation of anthropometric indicators of nutritional status. Bull World Health Organ 1986; 64: 929.
45. Bailey BE, Ferro-Luzzi A. Use of body mass index of adults in assessing individual and community nutritional status. Bull World Health Organ 1995 3: 673.
46. Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med 1998; 17: 1623-1624.
47. Viera AJ, Garrett JM. Understanding interobserver agreement: the Kappa statistic. Fam Med 2005; 37: 360-363.
48. Bolstad B, Irizarry R, Astrand M, Speed T. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185-193.
49. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 1995; 57: 289-300.